Howard Schiller made Valeant CFO
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals has appointed Howard Schiller executive vice-president and chief financial officer, effective 1 December. Mr Schiller, who recently retired from Goldman Sachs after 24 years, most recently serving as chief operating officer for the investment banking division, will take over the position from Philip Loberg, Valeant's interim CFO. Mr Loberg will remain at the company in a different, as yet unspecified, role.